Rompe Pecho CF

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Rompe Pecho CF
Generic name: BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR
Manufacturer: Dextrum Laboratories, Inc
Product type: HUMAN OTC DRUG
SPL set ID: 401a97af-36ae-4e54-e063-6294a90ab3ee
SPL ID: 401a97af-36af-4e54-e063-6294a90ab3ee
Version: 1
Effective date: 2025-10-01
Source export date: 2026-09-28
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:08:51

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		Rompe Pecho CF	openfda.brand_name
generic name		BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR	openfda.generic_name
manufacturer name		Dextrum Laboratories, Inc	openfda.manufacturer_name
ndc	package	65852-013-06	openfda.package_ndc
ndc	product	65852-013	openfda.product_ndc
ndc11	package	65852001306	derived:openfda.package_ndc
rxcui		2676758	openfda.rxcui
spl id		401a97af-36af-4e54-e063-6294a90ab3ee	id
spl set id		401a97af-36ae-4e54-e063-6294a90ab3ee	set_id
unii		9D2RTI9KYH	openfda.unii
unii		IXA7C9ZN03	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Warnings Do no exceed recommended dosage Do not use if you are now taking a prescription monoamine oxidase inhibitor(MAOI) (certain drugs for depression, psychiatric or emotional condition, or Parkinson's disease), or 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI ask a doctor or pharmacist before taking this product. Warning

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.